Shire recalls some Daytrana shipments

Mom, I can't get my ADHD patch on! Shire is recalling some lots of Daytrana, its attention deficit hyperactivity disorder patch--not because of safety issues, but because patients are having a hard time removing the release liner so they can administer the drug. The withdrawal is expected to cost the British drug maker some $10 million.

- see this release
- here's the report from MarketWatch

Related Articles:
FDA approves Daytrana ADHD patch
FDA signals a quick approval for Shire's ADHD drug
CDC estimates reignite ADHD controversy